Circulating Plasma Cells in Monoclonal Gammopathies.

Area of Science:

• Hematology
• Immunology
• Clinical Diagnostics

Background:

• Monoclonal gammopathies involve clonal plasma cells in bone marrow, with peripheral blood presence indicating prognosis.
• Circulating plasma cells (CPCs) number predicts survival and relapse risk in monoclonal gammopathies.
• Mechanisms of CPC expansion from bone marrow are unclear, potentially involving adhesion molecule expression.

Purpose of the Study:

• To review multiparametric flow cytometry for CPC analysis in peripheral blood.
• To compare CPC detection methods and assess clinical relevance.
• To emphasize the need for standardization in CPC analysis.

Main Methods:

• Multiparametric flow cytometry for enumerating CPCs in peripheral blood.
• Phenotypic profiling and clonality confirmation of CPCs.
• Review of existing detection methods and their clinical utility.

Main Results:

• Multiparametric flow cytometry offers sensitive CPC detection, even at low quantities.
• Standardized analysis can establish diagnostic thresholds for plasma cell leukemia.
• Phenotypic analysis may predict CPC behavior and patient outcomes.

Conclusions:

• Standardized multiparametric flow cytometry is vital for diagnosing plasma cell leukemia and prognosing monoclonal gammopathies.
• This method's sensitivity aids in identifying circulating plasma cells.
• Further analysis of CPC phenotype can elucidate their role in disease progression.